2030 年までのヨーロッパのサルコペニア治療市場予測 - 地域分析 - 治療タイプ別 (ビタミン D およびカルシウム サプリメント、タンパク質サプリメント、ビタミン B12 サプリメントなど) および流通チャネル別 (薬局、小売チャネル、オンライン チャネルなど)
成人の栄養失調とビタミン欠乏の増加がヨーロッパのサルコペニア治療市場を後押し
栄養失調は、サルコペニアの主な危険因子の1つです。WHOによると、2021年時点で世界中で約23億人の成人が栄養失調であり、これは世界人口の約30%に相当します。報告されている危険因子の中で、タンパク質エネルギー欠乏はサルコペニアの頻繁な原因です。さらに、ビタミン D 欠乏症または不十分症は、がん、肥満、心血管疾患、サルコペニアなどの複数の病気のリスク増加と正の相関関係にあります。米国国立衛生研究所 (NIH) によると、世界の人口の約 50% がビタミン D 不足に悩まされており、約 10 億人がビタミン D 欠乏症です。
ヨーロッパのサルコペニア治療市場の概要
ヨーロッパのサルコペニア治療市場は、ドイツ、フランス、英国、イタリア、スペイン、その他のヨーロッパに分かれています。ヨーロッパは世界のサルコペニア治療市場で重要な位置を占めており、予測期間中に顕著な CAGR を記録すると予測されています。
ドイツは、ヘルスケアに対する革新的なアプローチにより魅力的な市場です。連邦統計局によると、この国の医療費は2021年に4,740億米ドルに達しました。 高齢化社会のドイツでは、サルコペニアとサルコペニア性肥満（SO）の認識が徐々に高まっています。 サルコペニアとSOは、70歳以上のドイツ人男性では比較的まれです（<5％）。 そのため、整形外科疾患の症例の増加と栄養補助食品の需要の高まりが相まって、ドイツのサルコペニア治療市場の成長を牽引しています。
ヨーロッパのサルコペニア治療市場の収益と2030年までの予測（百万米ドル）
ヨーロッパのサルコペニア治療市場のセグメンテーション
ヨーロッパのサルコペニア治療市場は、治療タイプ、流通チャネル、国に分類されています。
治療タイプに基づいて、ヨーロッパのサルコペニア治療市場は、ビタミンDとカルシウムのサプリメント、タンパク質サプリメント、ビタミンB12サプリメント、その他に分類されています。ビタミンDとカルシウムのサプリメントセグメントは、2022年にヨーロッパのサルコペニア治療市場で最大のシェアを占めました。
流通チャネルの面では、ヨーロッパのサルコペニア治療市場は、薬局、小売チャネル、オンラインチャネル、その他に分類されています。薬局セグメントは、2022年にヨーロッパのサルコペニア治療市場で最大のシェアを占めました。
国別に見ると、ヨーロッパのサルコペニア治療市場は、ドイツ、フランス、イタリア、英国、スペイン、その他のヨーロッパに分割されています。 2022年、ヨーロッパのサルコペニア治療市場シェアはドイツが独占しました。
ヨーロッパのサルコペニア治療市場で事業を展開している大手企業には、アボット ラボラトリーズ、アムウェイ コーポレーション、バイエル AG、GSK Plc、メタジェニックス LLC、ネスレ ヘルス サイエンス SA、ノバルティス AG、ファイザー社、サノフィ SA などがあります。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Sarcopenia Treatment Market - Key Industry Dynamics
4.1 Europe Sarcopenia Treatment Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Upsurge in Geriatric Population
4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
4.3 Key Market Restraints:
4.3.1 Unavailability of Direct Interventions
4.4 Key Market Opportunities:
4.4.1 Products in Clinical Trial Phases
4.5 Future Trends:
4.5.1 Rising Awareness About Sarcopenia
4.6 Impact of Drivers and Restraints:
5. Sarcopenia Treatment Market - Europe Market Analysis
5.1 Europe Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
5.2 Europe Sarcopenia Treatment Market Forecast and Analysis
6. Europe Sarcopenia Treatment Market Analysis - By Treatment Type
6.1 Vitamin D and Calcium Supplement
6.1.1 Overview
6.1.2 Vitamin D and Calcium Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Protein Supplement
6.2.1 Overview
6.2.2 Protein Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Vitamin B12 Supplement
6.3.1 Overview
6.3.2 Vitamin B12 Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7. Europe Sarcopenia Treatment Market Analysis - By Distribution Channel
7.1 Pharmacies
7.1.1 Overview
7.1.2 Pharmacies : Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
7.2 Retail Channels
7.2.1 Overview
7.2.2 Retail Channels : Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Online Channels
7.3.1 Overview
7.3.2 Online Channels : Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others : Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
8. Europe Sarcopenia Treatment Market - Country Analysis
8.1 Europe
8.1.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.2 Germany Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.2.1 Germany Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.2.2 Germany Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.3 France Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.3.1 France Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.3.2 France Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.4 United Kingdom Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.4.1 United Kingdom Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.4.2 United Kingdom Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.5 Italy Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.5.1 Italy Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.5.2 Italy Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.6 Spain Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.6.1 Spain Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.6.2 Spain Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.7 Rest of Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.7.1 Rest of Europe Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.7.2 Rest of Europe Sarcopenia Treatment Market Breakdown by Distribution Channel
9. Sarcopenia Treatment Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Sarcopenia Treatment Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Bayer AG
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Metagenics LLC
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Nestle Health Science SA
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Novartis AG
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Pfizer Inc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Sanofi SA
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Amway Corp
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 GSK Plc
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Europe Sarcopenia Treatment Market Segmentation
Table 2. Sarcopenia Drug Under Clinical Development
Table 3. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
Table 4. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
Table 5. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
Table 6. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
Table 7. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 8. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 9. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 10. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 11. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 12. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 13. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 14. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 15. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 16. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 17. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 18. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 19. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
Table 20. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
Table 21. Glossary of Terms, Sarcopenia Treatment Market
List of Figures
Figure 1. Europe Sarcopenia Treatment Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Europe Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
Figure 4. Europe Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
Figure 5. Vitamin D and Calcium Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Protein Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Vitamin B12 Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Others: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Europe Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
Figure 10. Pharmacies : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Retail Channels : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Online Channels : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 13. Others : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Europe Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
Figure 15. Europe Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 16. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 17. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 18. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 19. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 20. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 21. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 22. Growth Strategies in the Sarcopenia Treatment Market
1. Abbott Laboratories
2. Amway Corp
3. Bayer AG
4. GSK Plc
5. Metagenics LLC
6. Nestle Health Science SA
7. Novartis AG
8. Pfizer Inc
9. Sanofi SA
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe sarcopenia treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe sarcopenia treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.